A novel gene delivery system targeting Tie2 for cancer gene therapy

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 1999-2004

  Hu, Aiqun ^c   Wu, Xianghua ^a,b,c   Li, Zonghai ^c   Wang, Huamao ^c   Li, Jingjun ^c   Yao, Ming ^c   Chen, Xianlian ^c   Qu, Shumin ^c   Xu, Yuhong ^d   Gu, Jianren ^c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gene therapy; p53 gene; Polyethylenimine; Tie2

Indexed keywords

ANGIOPOIETIN RECEPTOR; GA3 PEPTIDE; PEPTIDE; POLYETHYLENEIMINE; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; EPITHELIUM CELL; EXPRESSION VECTOR; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN TARGETING; REPORTER GENE; TUMOR GENE; TUMOR XENOGRAFT;

ANIMALS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; POLYETHYLENEIMINE; RECEPTOR, TIE-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955084678     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Zadeh G, Qian B, Okhowat A, Sabha N, Kontos CD and Guha A: Targeting the Tie2/Tek receptor in astrocytomas. Am J Pathol 164: 467-476, 2004.
2. De Palma M, Venneri MA and Naldini L: In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. Hum Gene Ther 14: 1193-1206, 2003.
3. Kircheis R, Wightman L, Schreiber A, Robitza B, Rössler V, Kursa M and Wagner E: Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8: 28-40, 2001.
4. Elfinger M, Maucksch C, Rudolph C: Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials 28: 3448-3455, 2007.
5. Larocca D, Jensen-Pergakes K, Burg MA and Baird A: Receptor-targeted gene delivery using multivalent phagemid particles. Mol Ther 3: 476-484, 2001.
6. Wu GY and Wu CH: Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262: 4429-4432, 1987.
7. Li Z, Zhao R, Wu X, Sun Y, Yao M, Li J, Xu Y and Gu J: Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J 19: 1978-1985, 2005.
8. Gautam A, Waldrep JC, Kleinerman ES, Xu B, Fung YK, T'Ang A and Densmore CL: Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes. Methods Mol Med 75: 607-618, 2003.
9. Ogris M, Walker G, Blessing T, Kircheis R, Wolschek M and Wagner E: Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release 91: 173-181, 2003.
10. De Jong M, Kwekkeboom D, Valkema R and Krenning EP: Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002. Eur J Nucl Med Mol Imaging 30: 463-469, 2003.
11. Barry MA, Dower WJ and Johnston SA: Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 2: 299-305, 1996.
12. Dales JP, Garcia S, Bonnier P, Duffaud F, Meunier-Carpentier S, Andrac-Meyer L, Lavaut MN, Allasia C and Charpin C: Tie2/Tek expression in breast carcinoma: Correlations of immunohistochemical assays and longterm follow-up in a series of 909 patients. Int J Oncol 22: 391-397, 2003.
13. Tanaka S, Sugimachi K, Yamashita Yi Y, Ohga T, Shirabe K, Shimada M, Wands JR and Sugimachi K: Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology 35: 861-867, 2002.
14. Raikwar SP, Temm CJ, Raikwar NS, Kao C, Molitoris BA and Gardner TA: Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model. Mol Ther 12: 1091-1100, 2005.
15. Lin P, Buxton JA, Acheson A, Radziejewski C, Maisonpierre PC, Yancopoulos GD, Channon KM, Hale LP, Dewhirst MW, George SE and Peters KG: Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci USA 95: 8829-8834, 1998.
16. Quinlan DC, Davidson AG, Summers CL, Warden HE and Doshi HM: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Re 52: 4828-4831, 1992.
17. Dolivet G, Merlin JL, Barberi-Heyob M, Ramacci C, Erbacher P, Parache RM, Behr JP and Guillemin F: In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector. Cancer Gene Ther 9: 708-714, 2002.
18. Wu X, Zhao R, Li Z, Yao M, Wang H, Han J, Qu S, Chen X, Qian L, Sun Y, Xu Y and Gu J: A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2. Biochem Biophys Res Commun 315: 1004-1010, 2004.
19. Kircheis R, Kichler A, Wallner G, Kursa M, Ogris M, Felzmann T, Buchberger M and Wagner E: Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 4: 409-418, 1997.
20. Elfinger M, Geiger J, Hasenpusch G, Uzgün S, Sieverling N, Aneja MK, Maucksch C and Rudolph C: Targeting of the beta(2)-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo. J Control Release 135: 234-241, 2009.
21. Gautam A, Densmore CL, Melton S, Golunski E and Waldrep JC: Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis. Cancer Gene Ther 9: 28-36, 2002.
22. Goula D, Becker N, Lemkine GF, Normandie P, Rodrigues J, Mantero S, Levi G and Demeneix BA: Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes. Gene Ther 7: 499-504, 2000.